RBC Capital Mkts resumed coverage on Thermo Fisher with a new price target
$TMO
Industrial Machinery/Components
Industrials
RBC Capital Mkts resumed coverage of Thermo Fisher with a rating of Sector Perform and set a new price target of $490.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/3/2026 | $540.00 | Buy → Hold | HSBC Securities |
| 6/2/2026 | $535.00 | Outperform | Wolfe Research |
| 5/15/2026 | $490.00 | Sector Perform | RBC Capital Mkts |
| 3/27/2026 | $610.00 | Buy | DZ Bank |
| 12/11/2025 | $660.00 | Neutral → Buy | Citigroup |
| 12/9/2025 | $685.00 | Buy | Goldman |
| 12/8/2025 | $750.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 12/2/2025 | $670.00 | Overweight | Morgan Stanley |
4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
HSBC Securities downgraded Thermo Fisher from Buy to Hold and set a new price target of $540.00
Wolfe Research resumed coverage of Thermo Fisher with a rating of Outperform and set a new price target of $535.00
RBC Capital Mkts resumed coverage of Thermo Fisher with a rating of Sector Perform and set a new price target of $490.00
New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face increasing pressure to generate hi
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the developm
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team highlighted the company's industry leadership and the essential role of its best-in-class products and services to customers around the world. "Our customers value Thermo Fisher as their trusted partner," said Marc N. Casper, chairman and chief executive officer, Thermo Fisher Scientific. "Our unique scale and depth of capabilities advance scientific discovery and position us incredibly well in an increasingly AI-enabled world." Casper continued, "We have a track record of delivering sh
SD - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
DEFA14A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
Seasoned external affairs executive to lead investor and public communications as company advances IMSR commercialization Terrestrial Energy Inc. (NASDAQ:IMSR) ("Terrestrial Energy" or the "Company"), a developer of proprietary Generation IV small modular nuclear power plants, today announced that Tyler Gronbach has joined the company as Vice President of Investor Relations and Public Relations. The appointment comes as Terrestrial Energy accelerates commercialization of its Integral Molten Salt Reactor (IMSR) and expands engagement with institutional investors, sell-side analysts and the financial media following its Nasdaq listing last year. Gronbach will report to CEO Simon Irish and
Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. This press release features multimedia. View the full release here: https://www.businesswire
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the developm
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2026. First Quarter Highlights First quarter revenue grew 6% to $11.01 billion. First quarter GAAP diluted earnings per share (EPS) grew 11% to $4.43. First quarter adjusted EPS grew 6% to $5.44. Delivered excellent performance in the first quarter, demonstrating the strength of our proven growth strategy, the power of our PPI Business System, and the continued active management of our company. Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the quarter. This includ
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the "Investors" section of our website, www.thermofisher.com. You can access the conference call by dialing (833) 470-1428 within the U.S. or +1 (646) 844-6383 outside the U.S. The access code is 723173. The earnings press release and related information can also be found in that sec
SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)
SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)